What are Merck's top-selling medications and vaccines? They are Keytruda, Gardasil/Gardasil 9, ProQuad/M-M-R II/Varivax, Animal Health ... to the FDA's Orange Book, it expires on February 24 ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

Sponsor:  Consultancy Media for Nobivac Spring and summer bring sunshine and outdoor fun—but they also come with hidden ...

The 15-valent conjugate vaccine was at least as effective as Pfizer's 13-valent Prevnar 13 in the study, which involved infants up to 15 months old, and will form the basis of regulatory filing to ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Rising competitive pressure on the diabetes franchise and persistent challenges for its human papillomavirus vaccine, Gardasil in China remain overhangs. There are concerns about Merck’s ability ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

and measles vaccine ProQuad earning ~$2.5bn. After that, Merck has an animal health segment that earned ~$6bn last year, or 9% of revenues, diabetes segment that earned $2.3bn, or 4% of revenues ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite this ...